Trial Profile

Phase 2 early intervention clinical study of VIASKIN® Peanut patch in children aged 6 to 12 months

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 27 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Peanut allergy immunotherapy (Primary)
Indications Peanut hypersensitivity
Focus Adverse reactions

Most Recent Events

27 Nov 2025 New trial record
30 Oct 2025 According to DBV Technologies media release, Dr. Gideon Lack is the co-principal investigator of the trial.
30 Oct 2025 According to DBV Technologies media release, details of the study will be presented in the American College of Allergy, Asthma & Immunology (ACAAI) 2025 Annual Scientific Meeting, November 6 -10, in Orlando, Florida.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com